All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Cell line-34826506

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	34826506	I105T	C	C	Cell line	D G R	View
2	34826506	L30F	C	C	Cell line	D G R	View
3	34826506	L37Q	C	C	Cell line	D G R	View
4	34826506	T33N	C	C	Cell line	D G R	View
5	34826506	T33Q	C	C	Cell line	D G R	View
6	34826506	L180M	RT	P	Cell line	D G R	View
7	34826506	M204I	RT	P	Cell line	D G R	View
8	34826506	M204V	RT	P	Cell line	D G R	View
9	34826506	M250V	RT	P	Cell line	D G R	View
10	34826506	S202G	RT	P	Cell line	D G R	View
11	34826506	V173L	RT	P	Cell line	D G R	View
12	34826506	F24Y	C	C	Cell line	G R	View
13	34826506	I105L	C	C	Cell line	G R	View
14	34826506	I105V	C	C	Cell line	G R	View
15	34826506	P134T	C	C	Cell line	G R	View
16	34826506	T109C	C	C	Cell line	G R	View
17	34826506	T109M	C	C	Cell line	G R	View
18	34826506	T109S	C	C	Cell line	G R	View
19	34826506	T114I	C	C	Cell line	G R	View
20	34826506	T33S	C	C	Cell line	G R	View
21	34826506	Y132F	C	C	Cell line	G R	View
22	34826506	Y38F	C	C	Cell line	G R	View
23	34826506	Y38H	C	C	Cell line	G R	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.